An objective, feature-by-feature comparison of GlycoFree and Cinnachroma — two blood sugar support supplements with different formula philosophies — covering ingredients, chromium dosing, label transparency, pricing, and practical suitability.
GlycoFree and Cinnachroma both target blood sugar metabolism support but take distinctly different approaches. Cinnachroma uses a simple, fully transparent four-ingredient formula centered on high-dose chromium picolinate (600 mcg) and Ceylon cinnamon. GlycoFree uses a broader eight-ingredient formula with chromium (400 mcg) plus berberine, banaba, gymnema, inulin, and more, though most are in an undisclosed proprietary blend. Cinnachroma wins on transparency; GlycoFree wins on ingredient breadth. Neither treats or cures diabetes.
No clinical head-to-head trials compare GlycoFree and Cinnachroma. This comparison is based on publicly available product label information and cannot determine which product produces better outcomes for any individual. Both are dietary supplements, not medications.
GlycoFree is a once-daily tablet by Neo Nature that combines chromium at 400 mcg (transparently disclosed) with a 200 mg proprietary blend of seven ingredients: berberine HCl, cinnamon extract 10:1, banaba extract (1% corosolic acid), gymnema pentaphyllum, inulin (chicory root), bitter melon extract 4:1, and L-leucine. It is manufactured in a GMP-certified US facility and backed by a 90-day money-back guarantee. A full breakdown is available on the GlycoFree ingredients page.
Cinnachroma is a blood sugar support supplement built around a lean, fully disclosed four-ingredient formula. Its primary active ingredient is chromium picolinate at 600 mcg per serving. This is paired with Ceylon cinnamon (Cinnamomum verum), zinc, and vanadium. The formula's philosophy prioritizes simplicity and dose transparency over ingredient breadth, making it one of the more evaluable blood sugar supplements from a label standpoint. Cinnachroma is manufactured in a GMP-certified facility in the USA.
| Feature | GlycoFree | Cinnachroma |
|---|---|---|
| Format | Tablet, once daily | Capsule, once daily |
| Number of Active Ingredients | 8 (1 disclosed + 7 in blend) | 4 (all individually disclosed) |
| Chromium Dose | 400 mcg (polynicotinate) | 600 mcg (picolinate) |
| Cinnamon Type | Cassia (Cinnamomum cassia) 10:1 extract | Ceylon (Cinnamomum verum) |
| Berberine Included? | Yes (in blend) | No |
| Prebiotic Fiber (Inulin) | Yes | No |
| Vanadium | No | Yes |
| Zinc | Not listed | Yes |
| Dose Transparency | Partial (chromium only) | Full label disclosure |
| Price Range | $49–$69 per bottle | Verify at official source |
| Guarantee | 90 days | Verify at official source |
| Manufacturing | USA, GMP-certified | USA, GMP-certified |
| Finished Product Clinical Study | Not available | Not available |
Both products lead with chromium, but there are meaningful differences in dose and form. Cinnachroma provides 600 mcg of chromium picolinate, while GlycoFree provides 400 mcg of chromium polynicotinate. Both doses fall within the range studied in clinical research (200 to 1,000 mcg per day). Both forms (picolinate and polynicotinate) are well-studied and considered comparable in bioavailability across most research contexts.
Cinnachroma's higher chromium dose gives it a numerical advantage on this specific ingredient. For someone whose primary interest is chromium supplementation, this difference is worth noting.
This is one of the more substantive ingredient-quality differences between the two products. GlycoFree uses Cinnamomum cassia (common cinnamon), while Cinnachroma uses Cinnamomum verum (Ceylon cinnamon, often called "true cinnamon").
Cassia cinnamon contains higher levels of coumarin, a naturally occurring compound that, in very high doses over extended periods, has been associated with liver concerns in sensitive individuals. Ceylon cinnamon contains negligible coumarin and is generally considered the safer choice for long-term daily supplementation. At typical supplement extract doses, cassia's coumarin content is unlikely to reach concerning levels, but Ceylon's lower coumarin profile is a genuine formulation quality advantage.
GlycoFree includes berberine HCl in its proprietary blend. Cinnachroma does not contain berberine. Berberine is the most extensively researched botanical compound for glucose metabolism support, though its clinical effects are demonstrated at 500 to 1,500 mg daily — doses almost certainly not achievable within GlycoFree's 200 mg total blend.
Regardless of dose, anyone taking prescription medications should note that berberine has documented interactions with cytochrome P450 drug-metabolism pathways. Cinnachroma's absence of berberine makes it a potentially lower-risk option for people on multiple medications. Full safety details are covered on the GlycoFree side effects page.
Cinnachroma includes vanadium, a trace mineral that has been studied in small-scale research for potential effects on insulin sensitivity and glucose metabolism. The evidence base for vanadium is more limited than for chromium or berberine, but it is a meaningful differentiating ingredient. GlycoFree does not include vanadium.
GlycoFree includes inulin from chicory root, providing a prebiotic fiber component that supports gut microbiome diversity. Emerging research links microbiome health to metabolic function. Cinnachroma does not include a prebiotic component. For those who see gut health as part of their metabolic support approach, this is a notable difference in GlycoFree's favor.
This is the most meaningful structural difference between the two products. Cinnachroma discloses the dose of every single ingredient on its label. GlycoFree discloses only chromium (400 mcg), with the other seven ingredients grouped into a 200 mg proprietary blend.
Full label transparency matters because it allows consumers to independently compare ingredient amounts against the doses used in clinical research. With Cinnachroma, you can verify whether chromium, cinnamon, zinc, and vanadium are present at meaningful quantities. With GlycoFree's blend, this is not possible for seven of the eight ingredients.
For evidence-minded consumers, Cinnachroma's transparency is a genuine advantage, particularly given the dose limitations inherent in any proprietary blend sharing 200 mg across multiple ingredients.
If ingredient variety across multiple research-supported pathways is the priority, GlycoFree covers more ground. Its formula targets insulin receptor sensitivity (chromium, berberine), cellular glucose transport (banaba, cinnamon), gut microbiome support (inulin), and additional botanical support (gymnema, bitter melon). Even at sub-clinical individual doses, the multi-pathway coverage may provide synergistic effects not captured by single-ingredient research.
Cinnachroma's leaner formula is easier to evaluate but does not offer the breadth of botanical support that GlycoFree attempts to provide.
GlycoFree contains berberine, which has documented interactions with cytochrome P450 enzymes (CYP2D6, CYP3A4) and can affect metabolism of certain prescription medications including blood thinners, statins, and some antibiotics. Cinnachroma does not contain berberine, making its drug interaction profile simpler. If you take prescription medications, consult your pharmacist or physician before using either product, but particularly before using any berberine-containing supplement.
GlycoFree is available at $69 per bottle (single), $59 per bottle (3-bottle package), and $49 per bottle (6-bottle package), exclusively through the official website. A 90-day money-back guarantee applies to official website purchases. Full pricing details are on the GlycoFree pricing page.
For Cinnachroma's current pricing and guarantee terms, always verify directly at the product's official website, as prices and promotions change. Both products are sold online only and are not available in retail stores such as Walmart or CVS.
GlycoFree and Cinnachroma serve overlapping but distinct audiences. Cinnachroma is the stronger choice for those who want full label transparency, a higher chromium dose, Ceylon cinnamon quality, and a simpler formula without berberine drug interaction concerns. GlycoFree is the stronger choice for those seeking a wider ingredient spread across multiple metabolic support pathways, including berberine (at sub-clinical doses) and prebiotic gut support.
Neither product has been clinically studied as a finished formula. Neither treats or cures diabetes. Both are best understood as complementary tools within a broader commitment to healthy diet, regular physical activity, and lifestyle management of blood sugar.
For a broader view of the blood sugar supplement market, see the best blood sugar supplements comparison page or the full GlycoFree review.
GlycoFree uses a multi-ingredient formula with chromium (400 mcg) plus a 200 mg proprietary blend of berberine, cinnamon, banaba, gymnema, inulin, bitter melon, and L-leucine. Cinnachroma takes a simpler, fully transparent approach centered on chromium picolinate (600 mcg), Ceylon cinnamon, zinc, and vanadium, with all doses individually disclosed on the label.
Cinnachroma typically provides 600 mcg of chromium picolinate per serving, compared to GlycoFree's 400 mcg of chromium polynicotinate. Both doses fall within the range studied in clinical research. The form differs: picolinate and polynicotinate are both well-studied forms with comparable bioavailability in most research.
Yes. Cinnachroma discloses all individual ingredient amounts on its label, which is a significant transparency advantage over GlycoFree, where seven of eight ingredients are grouped in an undisclosed 200 mg proprietary blend. Full label transparency allows independent comparison against clinical research doses.
GlycoFree includes berberine HCl from Phellodendron amurense bark in its proprietary blend. Cinnachroma does not contain berberine. If berberine is specifically part of your supplementation interest, GlycoFree is the relevant option, though the dose within the blend is likely sub-clinical compared to standalone berberine research amounts of 500 to 1,500 mg daily.
GlycoFree ranges from $49 to $69 per bottle depending on the package. For Cinnachroma's current pricing, verify directly at the product's official source as prices and promotions change. Both products are sold exclusively online and are not available in retail stores.
No. Neither product is FDA approved. Dietary supplements in the USA are regulated under DSHEA and do not require pre-market FDA approval. Both products claim GMP-certified manufacturing, which is a quality control standard, not a product efficacy approval.
Read the full ingredient analysis, dosage breakdown, and pricing guide before deciding.
Check GlycoFree Official Pricing